Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Observation × Thoracic × Clear all

Phase

Status

Recruiting 6 Active not recruiting 6 Completed 5 Not yet recruiting 4 Withdrawn 1 Unknown 1 Terminated 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 2 Thoracic 1 Other hematologic neoplasm 1 Myeloid 1 Gynecologic 1 Dermatologic 1

Conditions

Carcinoma, Non-Small-Cell Lung 1

Interventions

Cisplatin 31 Carboplatin 28 Pemetrexed 24 Radiotherapy 18 Docetaxel 17 pembrolizumab 15 durvalumab 15 Paclitaxel 15 Gemcitabine 15 Nivolumab 13 Radiosurgery 11 Etoposide 10 Erlotinib Hydrochloride 9 atezolizumab 8 Magnetic Resonance Spectroscopy 7 Drug Therapy 7 Cyclophosphamide 7 Bevacizumab 7 Taxes 6 Gefitinib 6 Platinum 5 sotorasib 4 Surveys and Questionnaires 4 Immunotherapy 4 Fluorodeoxyglucose F18 4 130-nm albumin-bound paclitaxel 4 1,2-diaminocyclohexaneplatinum II citrate 4 trametinib 3 etoposide phosphate 3 Vinorelbine 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03770299 2022-03-24

CheckMate 9TN

Bristol-Myers Squibb

Phase 2 Withdrawn

Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon ⚡